{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:17:42Z","timestamp":1791955062352,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017547","name":"Spark Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymthe.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:29:55Z","timestamp":1770395395000},"page":"3245-3269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4501-8402","authenticated-orcid":false,"given":"Apolonia","family":"Gardner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia R.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Kruczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Weist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barrio Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Nayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Haurigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-6387","authenticated-orcid":false,"given":"Constance L.","family":"Cepko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/ceo.13834","article-title":"Retinal pigment epithelium and age-related macular degeneration: A review of major disease mechanisms","volume":"48","author":"Somasundaran","year":"2020","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib2","first-page":"303","article-title":"Review of gene therapies for age-related macular degeneration","volume":"36","author":"Khanani","year":"2022","journal-title":"Eye Lond. Engl."},{"key":"10.1016\/j.ymthe.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bjophthalmol-2020-316195","article-title":"Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions","volume":"105","author":"Guimaraes","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrd4038","article-title":"New hope for dry AMD?","volume":"12","author":"Evans","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","article-title":"Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review","volume":"43","author":"Schultz","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ymthe.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: An approach to the etiology of age-related macular degeneration","volume":"99","author":"Crabb","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.005_bib7","article-title":"Abundant Lipid and Protein Components of Drusen","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.02.005_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8374647","article-title":"Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD","volume":"2018","author":"Hern\u00e1ndez-Zimbr\u00f3n","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ymthe.2026.02.005_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","article-title":"Mechanisms of age-related macular degeneration","volume":"75","author":"Ambati","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/1874364101913010090","article-title":"Age-related Macular Degeneration (AMD): A Review on its Epidemiology and Risk Factors","volume":"13","author":"Salimiaghdam","year":"2019","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.ymthe.2026.02.005_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.110128","article-title":"Ghost vessels in the eye: Cell free choriocapillaris domains in atrophic age-related macular degeneration","volume":"248","author":"Mullins","year":"2024","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2026.02.005_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17469899.2023.2287178","article-title":"Rod mediated dark adaptation, a functional test for early and intermediate AMD outcomes","volume":"19","author":"Owsley","year":"2024","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/joim.12227","article-title":"Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment","volume":"276","author":"Cheung","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymthe.2026.02.005_bib14","article-title":"Functions and Diseases of the Retinal Pigment Epithelium","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"AMD143","DOI":"10.1167\/iovs.18-24245","article-title":"An Acute Injury Model for the Phenotypic Characteristics of Geographic Atrophy","volume":"59","author":"Bhutto","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamaophthalmol.2019.1318","article-title":"Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular Degeneration","volume":"137","author":"Grassmann","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ajo.2024.02.021","article-title":"Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go","volume":"263","author":"Csaky","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib18","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3390\/jcm12155131","article-title":"Complement Inhibitors for Advanced Dry Age-Related Macular Degeneration (Geographic Atrophy): Some Light at the End of the Tunnel?","volume":"12","author":"Cruz-Pimentel","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymthe.2026.02.005_bib19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8","volume":"119","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2024.07.014","article-title":"Oral Antioxidant and Lutein\/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration","volume":"132","author":"Keenan","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.02.005_bib21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/antiox12071379","article-title":"Oxidative Stress and Antioxidants in Age-Related Macular Degeneration","volume":"12","author":"Kushwah","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.ymthe.2026.02.005_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","article-title":"The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD","volume":"60","author":"Datta","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2026.02.005_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/antiox13030362","article-title":"Light Pollution and Oxidative Stress: Effects on Retina and Human Health","volume":"13","author":"Salceda","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ymthe.2026.02.005_bib24","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI79735","article-title":"NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage","volume":"125","author":"Xiong","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.02.005_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145029","article-title":"Nrf2 overexpression rescues the RPE in mouse models of retinitis pigmentosa","volume":"6","author":"Wu","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.02.005_bib26","doi-asserted-by":"crossref","DOI":"10.34133\/research.0291","article-title":"AAV for Gene Therapy in Ocular Diseases: Progress and Prospects","volume":"6","author":"He","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.ymthe.2026.02.005_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.02.005_bib28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ymthe.2026.02.005_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib30","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a Transcription Factor for Stress Response and Beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1167\/iovs.15-17703","article-title":"Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide","volume":"57","author":"Ildefonso","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s42003-021-02100-6","article-title":"Molecular basis for the disruption of Keap1\u2013Nrf2 interaction via Hinge & Latch mechanism","volume":"4","author":"Horie","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2013.10.024","article-title":"Nrf2 signaling is impaired in the aging RPE given an oxidative insult","volume":"119","author":"Sachdeva","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2026.02.005_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1871527316666170102120211","article-title":"Preventive and protective roles of dietary Nrf2 activators against central nervous system diseases","volume":"16","author":"Sun","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ymthe.2026.02.005_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2012.08.032","article-title":"Dietary Nrf2 activators inhibit atherogenic processes","volume":"225","author":"Juurlink","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymthe.2026.02.005_bib36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/acn3.553","article-title":"The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis","volume":"5","author":"Hammer","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.005_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mam.2012.06.003","article-title":"Animal models of age related macular degeneration","volume":"33","author":"Pennesi","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ymthe.2026.02.005_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.111514","article-title":"Retinal degeneration rat model: A study on the structural and functional changes in the retina following injection of sodium iodate","volume":"196","author":"Koh","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.ymthe.2026.02.005_bib40","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1167\/iovs.16-21255","article-title":"Course of Sodium Iodate\u2013Induced Retinal Degeneration in Albino and Pigmented Mice","volume":"58","author":"Chowers","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib41","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s11064-010-0248-6","article-title":"Sodium Iodate Selectively Injuries the Posterior Pole of the Retina in a Dose-Dependent Manner: Morphological and Electrophysiological Study","volume":"35","author":"Machali\u0144ska","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymthe.2026.02.005_bib42","doi-asserted-by":"crossref","first-page":"19064","DOI":"10.1074\/jbc.M309881200","article-title":"Analysis of the VMD2 Promoter and Implication of E-box Binding Factors in Its Regulation","volume":"279","author":"Esumi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.02.005_bib43","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1167\/iovs.13-12477","article-title":"Assessing Sodium Iodate\u2013Induced Outer Retinal Changes in Rats Using Confocal Scanning Laser Ophthalmoscopy and Optical Coherence Tomography","volume":"55","author":"Yang","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib44","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1073\/pnas.1821000116","article-title":"AAV cis-regulatory sequences are correlated with ocular toxicity","volume":"116","author":"Xiong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.005_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-642-41199-1_6","article-title":"Cone arrestin: deciphering the structure and functions of arrestin 4 in vision","volume":"219","author":"Craft","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cne.901880204","article-title":"Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy","volume":"188","author":"Carter-Dawson","year":"1979","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-0716-2651-1_20","article-title":"Electroretinogram (ERG) to Evaluate the Retina Using Mouse Models","volume":"2560","author":"Liu","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib48","series-title":"Retinal Degeneration: Methods and Protocols","first-page":"285","article-title":"Phenotyping of Mouse Models with OCT","author":"Ochakovski","year":"2019"},{"key":"10.1016\/j.ymthe.2026.02.005_bib49","series-title":"AAV-Associated Toxicity Caused by Transgene Expression in the Retinal Pigment Epithelium","author":"Hong","year":"2023"},{"key":"10.1016\/j.ymthe.2026.02.005_bib50","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.ymthe.2026.02.005_bib51","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2011"},{"key":"10.1016\/j.ymthe.2026.02.005_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3438","article-title":"Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses","volume":"13","author":"Chan","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.005_bib53","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV Serotypes 1\u20139 Mediated Gene Expression and Tropism in Mice After Systemic Injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.005_bib54","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/ars.2023.0409","article-title":"A core NRF2 gene set defined through comprehensive transcriptomic analysis predicts selective drug resistance and poor multicancer prognosis","volume":"41","author":"Luo","year":"2024","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ymthe.2026.02.005_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exer.2017.10.023","article-title":"Phenotypic characterization of P23H and S334ter rhodopsin transgenic rat models of inherited retinal degeneration","volume":"167","author":"LaVail","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2026.02.005_bib56","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1167\/iovs.12-9662","article-title":"The Rd8 Mutation of the Crb1 Gene Is Present in Vendor Lines of C57BL\/6N Mice and Embryonic Stem Cells, and Confounds Ocular Induced Mutant Phenotypes","volume":"53","author":"Mattapallil","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/ars.2006.8.197","article-title":"Oxidative Stress, Accumulation of Biological \u201cGarbage\u201d","volume":"8","author":"Terman","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ymthe.2026.02.005_bib58","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.3390\/ijms22179218","article-title":"Sodium Iodate-Induced Degeneration Results in Local Complement Changes and Inflammatory Processes in Murine Retina","volume":"22","author":"Enzbrenner","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib59","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0749.1992.tb00568.x","article-title":"The effect of sodium iodate and melanin on the formation of glyoxylate","volume":"5","author":"Baich","year":"1992","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.ymthe.2026.02.005_bib60","doi-asserted-by":"crossref","first-page":"13943","DOI":"10.1073\/pnas.93.24.13943","article-title":"NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development","volume":"93","author":"Chan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.005_bib61","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ymthe.2026.02.005_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313053","article-title":"Different Therapeutic Approaches for Dry and Wet AMD","volume":"25","author":"Marchesi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.02.005_bib63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/hum.2015.130","article-title":"Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases","volume":"27","author":"Ye","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.005_bib64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/75080","article-title":"A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation","volume":"6","author":"Duan","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.005_bib65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41587-025-02565-4","article-title":"Spatial genomics of AAV vectors reveals mechanism of transcriptional crosstalk that enables targeted delivery of large genetic cargo","volume":"44","author":"Coughlin","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.02.005_bib66","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.omtm.2020.10.003","article-title":"In Situ Detection of Adeno-associated Viral Vector Genomes with SABER-FISH","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.02.005_bib67","series-title":"Treatments for Dry Age-Related Macular Degeneration and Stargardt Disease: A Systematic Review (NIHR Journals Library)","article-title":"Introduction to age-related macular degeneration","author":"Waugh","year":"2018"},{"key":"10.1016\/j.ymthe.2026.02.005_bib68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omtm.2017.04.003","article-title":"Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury","volume":"5","author":"Fujita","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.02.005_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2023.1270838","article-title":"The untapped potential of targeting NRF2 in neurodegenerative disease","volume":"4","author":"Chen","year":"2023","journal-title":"Front. Aging"},{"key":"10.1016\/j.ymthe.2026.02.005_bib70","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1038\/s41467-025-58778-3","article-title":"AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain","volume":"16","author":"Costa-Verdera","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.02.005_bib71","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2421978122","article-title":"RPE-specific MCT2 expression promotes cone survival in models of retinitis pigmentosa","volume":"122","author":"Chandler","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.005_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2020.105788","article-title":"Retinal layer segmentation in rodent OCT images: Local intensity profiles & fully convolutional neural networks","volume":"198","author":"Morales","year":"2021","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.ymthe.2026.02.005_bib73","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.12659\/MSM.905569","article-title":"Isolation and Culture of Primary Mouse Retinal Pigment Epithelial (RPE) Cells with Rho-Kinase and TGF\u03b2R-1\/ALK5 Inhibitor","volume":"23","author":"Shen","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ymthe.2026.02.005_bib74","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66240","article-title":"AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa","volume":"10","author":"Xue","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2026.02.005_bib75","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2307\/2346786","article-title":"Symbolic Description of Factorial Models for Analysis of Variance","volume":"22","author":"Wilkinson","year":"1973","journal-title":"Appl. Stat."}],"updated-by":[{"DOI":"10.1016\/j.ymthe.2026.03.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000}},{"DOI":"10.1016\/j.ymthe.2026.03.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000}}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:16:26Z","timestamp":1788178586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1525001626000912"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.005","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.07.09.663952","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}